Oxford Gene Technology releases latest version of aCGH data analysis software

26 March 2014 (Last Updated March 26th, 2014 01:00)

Provider of innovative genetics research and biomarker solutions to advance molecular medicine, Oxford Gene Technology (OGT), has released the 4.5.3 version of its CytoSure Interpret Software, developed for array comparative genomic hybridisation (aCGH) analysis.

oxford

Provider of innovative genetics research and biomarker solutions to advance molecular medicine, Oxford Gene Technology (OGT), has released the 4.5.3 version of its CytoSure Interpret Software, developed for array comparative genomic hybridisation (aCGH) analysis.

The new software is a powerful and easy-to-use package for the analysis of aCGH data, the gold-standard for copy number variation (CNV) detection.

With a combination of advanced features, including automatic aberration classification, the software provides the choice of standardised or customised user-defined data analysis.

In addition to this latest version of software, the company has introduced several innovative new features that further facilitate and standardise data analysis workflow in order to deliver rapid access to meaningful results.

"The automatic aberration classification enables users to tailor the software to automatically perform an initial classification of any detected CNV, accelerating analysis and standardising the interpretation process."

Using information available in online databases such as DECIPHER and settings defined by the user, the automatic aberration classification enables users to tailor the software to automatically perform an initial classification of any detected CNV, accelerating analysis and standardising the interpretation process.

The new technology provides simultaneous access to sample and experiment information across a network, providing the potential for labs on multiple sites to access a central database.

In situations where IT infrastructures do not permit the access, the software provides additional functionality for exporting sample and experiment information into other databases, facilitating sharing of case information and aberration calls.

CytoSure Interpret Software also allows users to use standardised phenotype (human phenotype ontology - HPO) terms to simplify and normalise the phenotype description process via a HPO phenotype selector window, in addition to the free text phenotype field.

CytoSure product manager Dr Ruth Burton said: "Our dedicated software development team are continually implementing enhanced features and capabilities in response to new product development and customer feedback, reflecting the overall OGT strategy to provide the most effective products, services and support."


Image: OGT releases latest version of CytoSure software. Photo: courtesy of Oxford Gene Technology.